ArticleCancers2021

Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma.

Magdalena Rausch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.